Survival Rates of Children with Congenital Heart Disease continue to improve.

Similar documents
Adults with Congenital Heart Disease. Michael E. McConnell MD, Wendy Book MD Teresa Lyle RN NNP

Adult Congenital Heart Disease T S U N ` A M I!

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!!

Born Blue. Anesthesia and CHD. Kristine Faust, CRNA, MS, MBA, DNAP

How pregnancy impacts adult cyanotic congenital heart disease

When to implant an ICD in systemic right ventricle?

Cardiac Emergencies in Infants. Michael Luceri, DO

Congenital Heart Disease

Anatomy & Physiology

Screening for Critical Congenital Heart Disease

Adult Congenital Heart Disease: A Growing Problem. Dr. Gary Webb Cincinnati Children s Hospital Heart Institute

More History. Organization. Maternal Cardiac Disease: a historical perspective. The Parturient with Cardiac Disease 9/21/2012

Children with Single Ventricle Physiology: The Possibilities

Congenital heart disease: When to act and what to do?

Pregnancy, Heart Disease and Imaging. Hemodynamics. Decreased systemic vascular resistance. Physiology anemia

PREGNANCY AND CONGENITAL HEART DISEASE

Tom Gentles Paediatric Cardiologist Green Lane Paediatric and Congenital Cardiac Service Starship Children s Hospital

Absent Pulmonary Valve Syndrome

Slide 1. Slide 2. Slide 3 CONGENITAL HEART DISEASE. Papworth Hospital NHS Trust INTRODUCTION. Jakub Kadlec/Catherine Sudarshan INTRODUCTION

Patent ductus arteriosus PDA

Outline. Congenital Heart Disease. Special Considerations for Special Populations: Congenital Heart Disease

Congenital Heart Disease II: The Repaired Adult

CONGENITAL HEART DISEASE (CHD)

Congenital Heart Defects

Cardiovascular Pathophysiology: Right to Left Shunts aka Cyanotic Lesions

Cardiovascular Pathophysiology: Right to Left Shunts aka Cyanotic Lesions Ismee A. Williams, MD, MS Pediatric Cardiology

Foetal Cardiology: How to predict perinatal problems. Prof. I.Witters Prof.M.Gewillig UZ Leuven

Deok Young Choi, Gil Hospital, Gachon University NEONATES WITH EBSTEIN S ANOMALY: PROBLEMS AND SOLUTION

CYANOTIC CONGENITAL HEART DISEASES. PRESENTER: DR. Myra M. Koech Pediatric cardiologist MTRH/MU

Introduction. Study Design. Background. Operative Procedure-I

Cardiac Catheterization Cases Primary Cardiac Diagnoses Facility 12 month period from to PRIMARY DIAGNOSES (one per patient)

Uptofate Study Summary

Έγκυος και συγγενής καρδιοπάθεια: Τι πρέπει να γνωρίζει ο Καρδιολόγος Ενηλίκων

3/14/2011 MANAGEMENT OF NEWBORNS CARDIAC INTENSIVE CARE CONFERENCE FOR HEALTH PROFESSIONALS IRVINE, CA. MARCH 7, 2011 WITH HEART DEFECTS

September 26, 2012 Philip Stockwell, MD Lifespan CVI Assistant Professor of Medicine (Clinical)

How to manage the pregnant woman with heart disease

Adult Congenital Heart Disease: The Scope of the Problem

The modified natural history of congenital heart disease

The complications of cardiac surgery:

Long Term outcomes after surgical interventions for Congenital Heart Disease (CHD)

Pediatric Echocardiography Examination Content Outline

Paediatrics Revision Session Cardiology. Emma Walker 7 th May 2016

Antithrombotic therapy for patients with congenital heart disease. George Giannakoulas, MD, PhD AHEPA University Hospital Thessaloniki

Research Presentation June 23, Nimish Muni Resident Internal Medicine

CONGENITAL HEART LESIONS ((C.H.L

Congenital Heart Disease An Approach for Simple and Complex Anomalies

Common Defects With Expected Adult Survival:

9/8/2009 < 1 1,2 3,4 5,6 7,8 9,10 11,12 13,14 15,16 17,18 > 18. Tetralogy of Fallot. Complex Congenital Heart Disease.

Adult Congenital Heart Disease: What Every Practitioner Should Know

5.8 Congenital Heart Disease

Congenital Heart Disease Patient and Pregnancy

Adult with Cyanotic Congenital Heat Disease

Notes by Sandra Dankwa 2009 HF- Heart Failure DS- Down Syndrome IE- Infective Endocarditis ET- Exercise Tolerance. Small VSD Symptoms -asymptomatic

Neonatal Single Ventricle Heart Disease Recognition, Management, Counseling

Cardiac Disease in Pregnancy

RF & RHD Workshop 22 nd March MANAGEMENT of RHEUMATIC HEART DISEASE in PREGNANCY. Dr Dorothy Radford

Although most patients with Ebstein s anomaly live

Congenital Heart Disease in the Adult Presenting for Non-Cardiac Surgery

"Lecture Index. 1) Heart Progenitors. 2) Cardiac Tube Formation. 3) Valvulogenesis and Chamber Formation. 4) Epicardium Development.

S. Bruce Greenberg, MD FNASCI and President, NASCI Professor of Radiology and Pediatrics University of Arkansas for Medical Sciences

Coarctation of the aorta

M/3, cc-tga, PS, BCPC(+) Double Switch Operation

Perimembranous VSD: When Do We Ask For A Surgical Closure? LI Xin. Department of Cardiothoracic Surgery Queen Mary Hospital Hong Kong

ESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy

Tetralogy of Fallot Latest data in risk stratification and replacement of pulmonic valve

East and Central African Journal of Surgery Volume 12 Number 2 November /December 2007

SURGICAL TREATMENT AND OUTCOME OF CONGENITAL HEART DISEASE

가천의대길병원소아심장과최덕영 PA C IVS THE EVALUATION AND PRINCIPLES OF TREATMENT STRATEGY

Surgical options for tetralogy of Fallot

Mid-term Result of One and One Half Ventricular Repair in a Patient with Pulmonary Atresia and Intact Ventricular Septum

Palliative Care and Paediatric Cardiac Patients 5 th Annual APPM Paediatric Palliative Care Study Day

Introduction. Pediatric Cardiology. General Appearance. Tools of Assessment. Auscultation. Vital Signs

Data Collected: June 17, Reported: June 30, Survey Dates 05/24/ /07/2010

DIAGNOSIS, MANAGEMENT AND OUTCOME OF HEART DISEASE IN SUDANESE PATIENTS

Notes: 1)Membranous part contribute in the formation of small portion in the septal cusp.

Surgical Management of TOF in Adults. Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital

Management of complex CHD in adults

What is the Definition of Small Systemic Ventricle. Hong Ryang Kil, MD Department of Pediatrics, College of Medicine, Chungnam National University

Congenital Heart Disease: Physiology and Common Defects

Valve Disease in the Pregnant Patient

Fontan Deterioration in Pediatric Cardiologist s s View. Pusan National University Hospital Hyoung Doo Lee M.D.

Surgical Procedures. Direct suture of small ASDs Patch repair Transcatheter closure with a prosthetic device called occluder

Anesthetic Considerations in Adults with Congenital Heart Disease

Adult Congenital Heart Disease: What All Echocardiographers Should Know Sharon L. Roble, MD, FACC Echo Hawaii 2016

Καρδιοπάθειες και κύηση. Υπάρχουν ενδείξεις διακοπής; Λαζαρίδου Φωτεινή, ΕΒ Καρδιολόγος Νοσοκομείο «Αγ Παύλος», Θεσσαλονίκη

When is Risky to Apply Oxygen for Congenital Heart Disease 부천세종병원 소아청소년과최은영

Glenn Shunts Revisited

ECHOCARDIOGRAPHIC APPROACH TO CONGENITAL HEART DISEASE: THE UNOPERATED ADULT

Hemodynamic assessment after palliative surgery

veins. This mixing of oxygenated and deoxygenated blood in the functionally single atrium means that the patient will continue to be desaturated, with

Mitral Valve Disease, When to Intervene

Objective 2/9/2012. Blood Gas Analysis In The Univentricular Patient: The Need For A Different Perspective. VENOARTERIAL CO2 GRADIENT

Pathophysiology: Left To Right Shunts

Pamela Heggie, RN BN Clinic Coordinator Northern Alberta Adult Congenital Heart (NAACH) Clinic Mazankowski Heart Institute

Management of Heart Failure and Cardiomyopathies in Pregnancy

Maternal Cardiac Disease Diagnosis and Management

Fundamentals of Congenital heart surgery in the adult

Heart and Lungs. LUNG Coronal section demonstrates relationship of pulmonary parenchyma to heart and chest wall.

Maternal Cardiac Disease In Pregnancy. August 25, 2017 PREGNANCY ECHO CONFERENCE

Transcription:

DOROTHY RADFORD

Survival Rates of Children with Congenital Heart Disease continue to improve. 1940-20% 1960-40% 1980-70% 2010->90% Percentage of children with CHD reaching age of 18 years

1938 First Patent Ductus Arteriosus ligated by Dr Robert Gross 7 year old girl. He was Chief Resident in Surgery. His chief was away on leave. He had practiced in autopsy room and animal labs. Successful. The girl lived into her 80 s. Gross & Hubbard JAMA 1939 Surgical ligation of PDA

CYANOTIC LESIONS - TETRALOGY of FALLOT /PULMONARY ATRESIA FIRST PALLIATIVE OPERATION: BLALOCK-TAUSSIG SHUNT 1944 ALFRED BLALOCK HELEN TAUSSIG

SURGERY FOR ASD 1952 Dr John Lewis closed an ASD in a 5 year old girl using hypothermia and inflow stasis SUCCESSFUL OPEN HEART SURGERY Gott V L -Ann Thorac Surg 2005

1955 CROSS-CIRCULATION SURGERY LILLEHEI Surgical correction of VSD, Tetralogy of Fallot & Atrio-ventricular Canal defect Lillehei: The first open-heart repairs. Ann Thorac Surg 1986

HEART LUNG BYPASS MACHINE Dr John Gibbon 1953 Stoney -Evolution of CPB: Circ 2009

1971 Dr Francois Fontan Diagram from original article 1929-2018 Repair of Tricuspid Atresia Fontan & Baudet: Surgical repair of tricuspid atresia. Thorax 1971

FONTAN CONCEPT Separate systemic & pulmonary flows: (a) connect systemic veins directly to pulmonary arteries (b) use single ventricle as systemic pump REQUIRE 1. Adequate preload 2.Low pulmonary artery pressures 3.Negative intrathoracic pressures for flow to lungs

SINGLE VENTRICLE - Various types of Fontan operation A. CLASSIC FONTAN B. LATERAL TUNNEL C. EXTERNAL CONDUIT

SEQUENCE FOR A TRICUSPID ATRESIA PATIENT Balloon atrial septostomy Shunts Fontan completion Hemi-Fontan

PREVIOUSLY UNTREATABLE LESIONS BECAME TREATABLE PALLIATED BUT NOT CURED Double inlet left ventricle with outflow chamber Unbalanced atrio-ventricular canal defect with hypoplastic right ventricle Heterotaxia syndromes -single V,TAPVD etc

HYPOPLASTIC LEFT HEART SYNDROME For years babies with this condition were untreatable. They would die as the ductus arteriosus closed.

HYPOPLASTIC LEFT HEART SYNDROME Norwood et al; J Thorac Cardiovas Surg 1981 NORWOOD PROCEDURE 1981 FIRST OF THREE STAGED OPERATIONS-FONTAN 3RD

ADULT CONGENITAL HEART PATIENTS

AUSTRALIA & NEW ZEALAND FONTAN REGISTRY Ongoing studies & reports

Number Living 1400 1300 1200 1100 1000 900 800 700 600 500 400 300 200 100 0 ECC LT AP Number of Patients Alive with a Fontan Circulation Greater than 1500 in ANZ Registry 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982 1981 1980 1979 1978 1977 1976 Year

Number of Patients AGES of FONTAN PATIENTS IN ANZ FONTAN REGISTRY 500 465 450 400 412 350 300 284 250 200 150 140 100 50 54 0 <10 10-18 19-29 30-39 >40 Age Group WANTING TO CONSIDER PREGNANCY

FONTAN HAEMODYNAMICS PRELOAD CARDIAC OUTPUT IS DEPENDENT ON THIS. No pump on pulmonary side. Relatively low CO. PULMONARY VASCULAR RESISTANCE should be low SYSTEMIC VENTRICULAR FUNCTION

AVOID FONTAN PHYSIOLOGY Decreased filling pressure (hypovolaemia) Increased Pulmonary Vascular Resistance & Positive Pressure Ventilation(e.g. GA) Increased LA pressure (LV dysfunction & A-V valve regurgitation)

COMPLICATIONS - FONTAN OPERATION Arrhythmias Thromboembolism Liver disease Protein-losing enteropathy Systemic ventricular dysfunction Hypoxaemia with shunts Plastic bronchitis Pregnancy risks Anaesthetic risks

Pundi et al: 40 Year follow-up after Fontan op J Am Coll Cardiol 2015

CYANOSIS FONTAN FENESTRATION Some desaturation from fenestration Also from veno-venous collaterals

PRE-CONCEPTION WORK-UP ECHO FULL MEDICAL EXAMINATION EXERCISE STRESS TEST MRI OXIMETRY

PREGNANCY HAEMODYNAMICS Increased Cardiac Output Increased Heart Rate Increased Plasma Volume Increased End Diastolic Volume Decreased Pulmonary Vascular Resistance Decreased Systemic Vascular R.

PREDICTORS OF POOR PREGNANCY OUTCOME IN FONTAN PATIENTS OXYGEN SATURATION < 90% ON AIR NYHA CLASS III OR IV BEFORE PREGANCY SYSTEMIC VENTRICLE EJECTION FRACTION < 40% PREVIOUS CARDIAC EVENT- Pulmonary oedema / Arrhythmia/ CVA SEVERE A-V VALVE REGURGITATION PROTEIN LOSING ENTEROPATHY FAILING FONTAN- hepatomegaly /ascites Brickner: CV management in preg CHD. Circulation 2014

MEDICATIONS in FONTAN PATIENTS ANTICOAGULANTS ACE INHIBITORS DIURETICS ANTI-ARRHYTHMICS ASPIRIN or WARFARIN CHANGE to LMW HEPARIN CEASE USE LOWEST EFFECTIVE DOSE CEASE SPIRONOLACTONE BETA-BLOCKERS CONTINUE AHA: Management of Pregnancy in complex CHD. Circulation 2017

MATERNAL CONCERNS in Fontan Pregnancy SUPRAVENTRICULAR ARRHYTHMIAS 3-37% PREGNANCY RELATED BLEEDING 5-50% Post partum haemorrhage 14% HEART FAILURE 3-11% Decline in NYHA function THROMBO-EMBOLIC EVENTS HYPOXAEMIA REVIEWS NO MATERNAL DEATHS 1.Ropero et al; 2018 Circulation: Cardiovasc Qual Outcomes 2.Moroney et al; 2018 Obstetric Medicine

FOETAL OUTCOMES LIVE BIRTHS 45% MISCARRIAGES 45% ELECTIVE TERMINATIONS 7% PREMATURITY 60% SMALL FOR GESTATION 25% NEONATAL DEATH 5%

FONTAN DELIVERY OUTCOMES PREMATURE MEMBRANE RUPTURE 10-14% CAESAREAN SECTION DELIVERY 57% ( 42-79%) EMERGENCY C SECTION RATE WAS GREATER THAN USUAL RATE

CONCERNS FOR FONTAN PATIENTS HYPOVOLAEMIA INCREASED INTRATHORACIC PRESSURE POSITIVE PRESSURE VENTILATION

RECOMMENDATIONS CAREFUL PRE-CONCEPTION MEDICAL ASSESSMENT & COUNSELLING EARLY MANAGEMENT PLAN FOR MEDICATIONS SPECIALISED REGULAR MULTI-DICIPLINARY PREGNANCY REVIEWS THROMBOPROPHYLAXIS- LMW HEPARIN PLANNED EPIDURAL ANAESTHETIC PLANNED VAGINAL BIRTH & MONITORING or PLANNED CAESAREAN SECTION DELIVERY ANTIBIOTIC COVER POST PARTUM HOSPITAL OBSERVATION

My Christmas Miracle Courier Mail 1999